|
The adjuvant combination PVP-AF04 enhances the antibody response towards SARS-CoV antigens
The adjuvant combination PVP-AF04 enhances the antibody response towards SARS-CoV antigens
Background
As of 2024, SARS-CoV-2 has caused over 1 million deaths in the United States and more than 7 million worldwide. As the virus continues to mutate, it is important to advance immunization efforts to combat the virus’s effects, especially...
Published: 3/24/2026
|
Updated: 5/8/2024
|
Inventor(s): Ofer Levy, Yoshine Saito, Francesco Borriello, David Dowling, Timothy Yu
Keywords(s):
Category(s): Technology Classifications > Disease Area > Infectious Disease, Technology Classifications > Disease Area > Infectious Disease > COVID-19, Technology Classifications > Invention Type > Vaccines > Adjuvants
|
